Journal of Orthopaedic Surgery and Research· 2026Q1
Teriparatide alleviates limb ischemia-associated posttraumatic bone loss: potential involvement of the AKT/HIF-1α/VEGFA signaling axis
- 0citations
- Q1SCImago
- 2026year
Short summary
Teriparatide (TPTD) treatment (40 µg/kg) significantly reduced bone loss and improved bone microarchitecture in a rat model of fracture with femoral artery ligation, a condition that exacerbates posttraumatic bone loss.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Rheumatology
RheumatologyMedicine